EcoDrugPlus

Solute Carrier Family 6 Member 3

Ensembl ID : ENSHCOG00000000952
Gene Symbol: SLC6A3
3 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSHCOG00000012602
Gene Symbol: SLC6A4
3 Cross references
201 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSHCOG00000016458
Gene Symbol: SLC6A9
3 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSHCOG00000012017
Gene Symbol: SLC9A3
3 Cross references
233 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSHCOG00000014233
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSHCOG00000009861
Gene Symbol: SSTR5
1 Cross references
183 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSHCOG00000006729
Gene Symbol: LOC109527815
2 Cross references
188 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSHCOG00000014174
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSHCOG00000009148
Gene Symbol: LOC109523214
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSHCOG00000011093
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSHCOG00000002803
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSHCOG00000006328
Gene Symbol: TACR1
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).